Lotus Pharmaceutical September Revenue Rises to NT$2.77B
Lotus Pharmaceutical reported September revenue of NT$2,766,433,000, compared with NT$1,213,533,000 a year earlier. Jan-Sep revenue was NT$24,818,419,000 versus NT$14,247,508,000.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lotus Pharmaceutical reported September revenue of NT$2,766,433,000, compared with NT$1,213,533,000 a year earlier. Jan-Sep revenue was NT$24,818,419,000 versus NT$14,247,508,000.